Ovarian Malignant Brenner Tumor
Downloads
Objectives: To report one malignant Brenner tumor (MBT) case in Dr. Soetomo Hospital, Surabaya, Indonesia, that underwent therapy from August 2016 to August 2017.
Case report: A woman aged 62 years underwent total abdominal hysterectomy and bilateral salphingo-oophorectomy surgery with histopathologic results of malignant Brenner Tumor. From immunohistochemical examination the expression of p63 was positive. The patient had been treated with Paclitaxel carboplatin chemotherapy for 5-cycles, with the results of the last post-chemotherapy evaluation showing no recidive mass.
Conclusion:There was only one case of malignant ovarian Brenner Tumor in Dr Soetomo Hospital, Surabaya, Indonesia, in 2014- 2016. The diagnosis can only be based on anatomic pathology examination. The specific tumor markers for malignant Brenner tumors have so far not been found.
Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. International journal of cancer. 2015 Mar 1;136(5).
Aziz MF. Gynecological cancer in Indonesia. Journal of gynecologic oncology. 2009 Mar 1;20(1):8-10.
Ries LA, Young Jr JL, Keel GE, et al. Cancer survival among adults: US SEER program, 1988–2001. Patient and tumor characteristics SEER Survival Monograph Publication. 2007:07-6215.
Lang SM, Mills AM, Cantrell LA. Malignant Brenner tumor of the ovary: Review and case report. Gynecologic Oncology Reports. 2017 Jul 3.
Hemalatha AL, Konanahalli P. Bilateral malignant Brenner tumor of ovary. J Obstet Gynecol India. 2005;55(1):81-2.
Bean LM, Anderson KM, Taylor K, et al. Malignant Brenner tumor of the ovary: A population-based study. Gynecologic Oncology. 2016 Jun 1;141:201
Dierickx I, Valentin L, Van Holsbeke C, et al. Imaging in gynecological disease (7): clinical and ultrasound features of Brenner tumors of the ovary. Ultrasound in Obstetrics & Gynecology. 2012 Dec 1;40(6):706-13.
Berek and Novak's. Gynecology 15th Edition: Lippincott Williams and Wilkins, 2012, 1560 pp, Hardcover, Rs. 2659 on www. flipkart. com, ISBN-139788184736106, ISBN-10818473610X.(2014)
Verma A, Chander B, Verma S, Soni A. Malignant brenner tumor of ovary. The Journal of Obstetrics and Gynecology of India. 2014 Apr 1:1-2.
Gezginç K, Karatayli R, Yazici F, et al. Malignant Brenner tumor of the ovary: analysis of 13 cases. International journal of clinical oncology. 2012 Aug 1;17(4):324-9.
Nasioudis D, Sisti G, Holcomb K, et al. Malignant Brenner tumors of the ovary; a population-based analysis. Gynecologic oncology. 2016 Jul 31;142(1):44-9.
Organisation mondiale de la santé, Centre international de recherche sur le cancer. WHO classification of tumours of female reproductive organs. IARC press; 2014.
Han JH, Kim DY, Lee SW, et al. Intensive systemic chemotherapy is effective against recurrent malignant Brenner tumor of the ovary: An analysis of 10 cases within a single center. Taiwanese Journal of Obstetrics and Gynecology. 2015 Apr 30;54(2):178-82.
Hull MG, Campbell GR. The malignant Brenner tumor. Obstetrics & Gynecology. 1973 Oct 1;42(4):527-hyhen.
Cuatrecasas M, Catasus L, Palacios J, Prat J. Transitional cell tumors of the ovary: a comparative clinicopathologic, immunohistochemical, and molecular genetic analysis of Brenner tumors and transitional cell carcinomas. The American journal of surgical pathology. 2009 Apr 1;33(4):556-67.
Roma AA, Masand RP. Different staining patterns of ovarian Brenner tumor and the associated mucinous tumor. Annals of diagnostic pathology. 2015 Feb 28;19(1):29-32.
Seidman JD, Khedmati F. Exploring the histogenesis of ovarian mucinous and transitional cell (Brenner) neoplasms and their relationship with Walthard cell nests: a study of 120 tumors. Archives of pathology & laboratory medicine. 2008 Nov;132(11):1753-60.
Austin RM, Norris HJ. Malignant Brenner tumor and transitional cell carcinoma of the ovary: a comparison. International journal of gynecological pathology. 1987 Mar 1;6(1):29-39.
Tlahuel JL, Heredia RD, Morales JR, Salazar JG. Transitional Cell Carcinoma of the Ovary: A case report and Review of the Literature. journal of Cancerology, (2014). 1:32-5
Ali RH, Seidman JD, Luk M, et al. Transitional cell carcinoma of the ovary is related to high-grade serous carcinoma and is distinct from malignant brenner tumor. International Journal of Gynecological Pathology. 2012 Nov 1;31(6):499-506.
Ingin RJ, Andola SK, Zubair AA. Transitional cell carcinoma of the ovary: case series and review of literature. Journal of clinical and diagnostic research: JCDR. 2014 Aug;8(8):FD07.
Gill SE, McGree ME, Weaver AL, et al. Optimizing the treatment of ovarian cancer: Neoadjuvant chemotherapy and interval debulking versus primary debulking surgery for epithelial ovarian cancers likely to have suboptimal resection. Gynecologic oncology. 2017 Feb 28;144(2):266-73.
Ozols RF, Bundy BN, Greer BE, et al. Phase III trial of carboplatin and paclitaxel comparedwith cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study. Journal of Clinical Oncology. 2003 Sep 1;21(17):3194-200.
Chundury A, Apicelli A, DeWees T, et al. Intensity modulated radiation therapy for recurrent ovarian cancer refractory to chemotherapy. Gynecologic oncology. 2016 Apr 30;141(1):134-9.
Pepin K, del Carmen M, Brown A, Dizon DS. CA-125 and Epithelial Ovarian Cancer: Role in Screening, Diagnosis, and Surveillance. American Journal of Hematology/Oncology®. 2014 Dec 1;10(6).
Dail, DH, Cagle PT, Marchevsky AM., et al. Metastases to the lung. In W. D. Travis, E. Brambilia, H. K. Muller-Hermelink, & C. Harris, Tumor of The Lung Lyon-France: IARC. 2004 ;121-124.
Ryback BJ, Ober WB, Bernacki Jr EG. Malignant Brenner tumor of the ovary. Report of three cases. Diagnostic gynecology and obstetrics. 1981;3(1):61-74.
Yamamoto R, Fujita M, Kuwabara M, et al. Malignant Brenner tumors of the ovary and tumor markers. Japanese journal of clinical oncology. 1999 Jun 1;29(6):308-13.
1. Copyright of the article is transferred to the journal, by the knowledge of the author, whilst the moral right of the publication belongs to the author.
2. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution-Non Commercial-Share alike (CC BY-NC-SA), (https://creativecommons.org/licenses/by-nc-sa/4.0/)
3. The articles published in the journal are open access and can be used for non-commercial purposes. Other than the aims mentioned above, the editorial board is not responsible for copyright violation
The manuscript authentic and copyright statement submission can be downloaded ON THIS FORM.
